KAUR, M.; RAI, J.; BAL, B. S.; KAUR, J. The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 3, n. 5, p. 902–907, 2017. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/1124. Acesso em: 27 sep. 2025.